SCHEMBL24326992

SCHEMBL24326992

Cc1cccc2c1N(S(=O)(=O)CC1CC(F)(F)C1)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.41
ALOX12 P18054 1/20 0.36
MAP3K5 Q99683 2/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
MAPT P10636 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 3/20 0.33
POLB P06746 2/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
HTT P42858 2/20 0.32
MAPK1 P28482 2/20 0.32
LMNA P02545 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CRHBP P24387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26777786 0.85 MAP3K5 (0.33) CNR2MAP3K5MEN1KMT2AMAPT
SCHEMBL24328583 0.79 ALOX12 (0.43) CNR2ALOX12MEN1KMT2ASLC6A2
SCHEMBL24326990 0.79 MAPT (0.46) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24326991 0.75 ALOX12 (0.42) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24326985 0.73 ALOX12 (0.40) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24327001 0.73 KMT2A (0.63) ALOX12MEN1KMT2AMAPTALDH1A1
SCHEMBL14591313 0.72 ALOX12 (0.47) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24326993 0.72 ALOX12 (0.44) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24326989 0.70 ALOX12 (0.46) CNR2ALOX12MEN1KMT2AMAPT
SCHEMBL24328580 0.69 KDM4E (0.55) CNR2ALOX12MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022063106-A1 INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS BEIGENE, LTD. (KY) 2022-03-31 WO disclosed